BlackRock’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,870
| Closed | -$42.7K | – | 5454 |
|
|
2023
Q3 | $42.7K | Sell |
8,870
-20
| -0.2% | -$96 | ﹤0.01% | 4962 |
|
|
2023
Q2 | $34.6K | Hold |
8,890
| – | – | ﹤0.01% | 5045 |
|
|
2023
Q1 | $22.3K | Hold |
8,890
| – | – | ﹤0.01% | 5155 |
|
|
2022
Q4 | $16.2K | Sell |
8,890
-41
| -0.5% | -$75 | ﹤0.01% | 5315 |
|
|
2022
Q3 | $61K | Sell |
8,931
-36
| -0.4% | -$246 | ﹤0.01% | 5225 |
|
|
2022
Q2 | $97K | Sell |
8,967
-3,573
| -28% | -$38.7K | ﹤0.01% | 5161 |
|
|
2022
Q1 | $280K | Sell |
12,540
-163
| -1% | -$3.64K | ﹤0.01% | 4941 |
|
|
2021
Q4 | $360K | Buy |
12,703
+431
| +4% | +$12.2K | ﹤0.01% | 4900 |
|
|
2021
Q3 | $800K | Buy |
12,272
+7,504
| +157% | +$489K | ﹤0.01% | 4554 |
|
|
2021
Q2 | $380K | Sell |
4,768
-33,465
| -88% | -$2.67M | ﹤0.01% | 4689 |
|
|
2021
Q1 | $5.08M | Buy |
38,233
+635
| +2% | +$84.4K | ﹤0.01% | 3873 |
|
|
2020
Q4 | $5.99M | Buy |
37,598
+226
| +0.6% | +$36K | ﹤0.01% | 3553 |
|
|
2020
Q3 | $3.93M | Sell |
37,372
-409
| -1% | -$43K | ﹤0.01% | 3583 |
|
|
2020
Q2 | $4.58M | Buy |
37,781
+2,419
| +7% | +$293K | ﹤0.01% | 3487 |
|
|
2020
Q1 | $2.77M | Sell |
35,362
-643
| -2% | -$50.4K | ﹤0.01% | 3496 |
|
|
2019
Q4 | $10.6M | Sell |
36,005
-6,882
| -16% | -$2.03M | ﹤0.01% | 3179 |
|
|
2019
Q3 | $7.75M | Buy |
42,887
+2,161
| +5% | +$391K | ﹤0.01% | 3287 |
|
|
2019
Q2 | $16.2M | Buy |
40,726
+3,503
| +9% | +$1.4M | ﹤0.01% | 2933 |
|
|
2019
Q1 | $17.4M | Sell |
37,223
-114
| -0.3% | -$53.3K | ﹤0.01% | 2806 |
|
|
2018
Q4 | $17.9M | Buy |
37,337
+10,063
| +37% | +$4.83M | ﹤0.01% | 2772 |
|
|
2018
Q3 | $18.6M | Buy |
27,274
+1,037
| +4% | +$707K | ﹤0.01% | 2886 |
|
|
2018
Q2 | $17.9M | Buy |
+26,237
| New | +$17.9M | ﹤0.01% | 2902 |
|